This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory non-compliance notification

BIO-key Nasdaq non-compliance

Analysis based on 7 articles · First reported Apr 20, 2026 · Last updated Jun 10, 2026

Sentiment
-60
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market is negatively impacted as BIO-key International faces potential delisting from Nasdaq-100, which could lead to a further decline in its stock price and investor confidence. This event highlights regulatory risks for companies failing to meet filing requirements.

Technology Cybersecurity

BIO-key International, a global leader in Identity and Access Management and biometric authentication technologies, received a notification from Nasdaq-100 for non-compliance with Listing Rule 5250(c)(1). This rule requires timely filing of periodic financial reports with the United States — United States Securities and Exchange Commission. The non-compliance stems from BIO-key International's failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The Nasdaq-100 Hearing Panel will consider this matter in determining BIO-key International's continued listing on the Nasdaq-100 Capital Market. This development follows a 41% decline in BIO-key International's stock over the past six months.

stock
BIO-key International received a non-compliance notification from The Nasdaq-100 Stock Market, LLC for failing to timely file its Quarterly Report on Form 10-Q, which could lead to delisting from the Nasdaq-100 Capital Market. Its stock has declined 41% over the past six months.
Importance 100.0 Sentiment -70.0
index
Nasdaq-100 issued a non-compliance notification to BIO-key International and its Hearing Panel will determine the company's continued listing status.
Importance 80.0 Sentiment 0.0
govactor
The United States — United States Securities and Exchange Commission is the regulatory body with which BIO-key International failed to file its required periodic financial reports.
Importance 30.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.